States Move to License AI Doctors as FDA Steps Back

Utah launched the nation's first AI-powered prescription refill program in January, partnering with startup Doctronic to let a chatbot renew about 190 chronic medications, as states move to license AI doctors amid FDA regulatory gaps. Security researchers manipulated the system to alter opioid dosing and generate misinformation, raising safety concerns from Utah regulators.

The rise of autonomous clinical chatbots tests the boundary between state medical licensure and federal device regulation, a development that affects how practitioners govern deployment, monitoring, and patient safety. According to PYMNTS, Utah launched the nation's first AI-powered prescription refill program in January, partnering with startup Doctronic to let a chatbot renew certain chronic medications; PYMNTS and the Associated Press report the pilot covers about 190 refillable drugs. STAT's May 11 opinion by Alon Bergman and a January Penn LDI briefing by Senior Fellow Bressman and co-authors both frame the FDA's current SaMD process as poorly matched to adaptive generative systems and propose licensure-style oversight. PYMNTS and The Verge report that security researchers were able to manipulate the Doctronic system to alter opioid dosing and generate misinformation, and PYMNTS/AP report Utah regulators voiced safety concerns after the pilot launched.